Computational tools have the ability to add tangible value to the development of biologic drugs. When utilized effectively, computational techniques can shorten timelines and enhance the cost-effectiveness of biologic drug development.
Computational Drug Development 2016 will bridge the gap between the application of computational tools for small molecule and biologic drug development. This meeting will bring together leading computational scientists from pharma, biotech, academia and software companies to evolve new solutions to focus the growing computational power on the richly accessible information generated in discovery and development.
Wyss Institute Senior Staff Scientist Jeffrey Way will speak at this event.
Input code WYS10 at the checkout to take advantage of an exclusive Wyss 10% discount.